XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and B common stock
Additional paid-in
Additional paid-in
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     432,796,720          
Beginning balance at Dec. 31, 2019 $ 1,715,050   $ 0 $ 2,223,749   $ 1,629 $ (510,328)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (105,891)           (105,891)  
Shares issued in connection with employee stock plans (in shares)     5,222,525          
Shares issued in connection with employee stock plans 31,406     31,406        
Issuance of common stock in connection with business combination (in shares)     357,017          
Issuance of common stock in connection with business combination 14,999     14,999        
Change in other comprehensive loss (5,061)         (5,061)    
Share-based compensation 79,562     79,562        
Tax withholding related to vesting of restricted stock units (in shares)     (722,606)          
Tax withholding related to vesting of restricted stock units (48,772)     (48,772)        
Conversion feature of convertible senior notes, due 2025, net of allocated costs 152,258     152,258        
Purchase of bond hedges in conjunction with issuance of convertible senior notes, due 2025 (149,200)     (149,200)        
Sale of warrants in conjunction with issuance of convertible senior notes, due 2025 99,500     99,500        
Issuance of common stock in conjunction with the conversion of senior notes (in shares)     1,109,980          
Issuance of common stock in conjunction with the conversion of senior notes 24,094     24,094        
Ending balance (in shares) at Mar. 31, 2020     438,763,636          
Ending balance at Mar. 31, 2020 1,807,945   $ 0 2,427,596   (3,432) (616,219)  
Beginning balance (in shares) at Dec. 31, 2019     432,796,720          
Beginning balance at Dec. 31, 2019 1,715,050   $ 0 2,223,749   1,629 (510,328)  
Ending balance (in shares) at Dec. 31, 2020     456,184,776          
Ending balance at Dec. 31, 2020 $ 2,681,569 $ (399,734) $ 0 2,955,464 $ (502,708) 23,328 (297,223) $ 102,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] mic:AccountingStandardsUpdate202006Member              
Net income (loss) $ 39,008           39,008  
Shares issued in connection with employee stock plans (in shares)     4,311,094          
Shares issued in connection with employee stock plans 32,891     32,891        
Change in other comprehensive loss (13,129)         (13,129)    
Share-based compensation 121,965     121,965        
Tax withholding related to vesting of restricted stock units (in shares)     (669,076)          
Tax withholding related to vesting of restricted stock units (152,013)     (152,013)        
Issuance of common stock in conjunction with the conversion of senior notes (in shares)     166,967          
Issuance of common stock in conjunction with the conversion of senior notes 3,816     3,816        
Exercise of bond hedges in conjunction with the conversion of senior notes, due 2022 (in shares)     (5,325,320)          
Ending balance (in shares) at Mar. 31, 2021     454,668,441          
Ending balance at Mar. 31, 2021 $ 2,314,373   $ 0 $ 2,459,415   $ 10,199 $ (155,241)